2024 annual financial data
Artiva Biotherapeutics 2024 Operating margin
Direct answer
Operating margin was -26,805.58%.
Operating income was -67,282,000 USD and net income was -58,493,000 USD.
Operating cash flow was -55,032,000 USD.
Get free Artiva Biotherapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 251,000 USD
- Operating income
- -67,282,000 USD
- Net income
- -58,493,000 USD
- Operating cash flow
- -55,032,000 USD